Treatment failure in a case of extensively drug-resistant tuberculosis associated with selection of a GyrB mutant causing fluoroquinolone resistance
- 26 April 2007
- journal article
- case report
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 26 (6) , 423-425
- https://doi.org/10.1007/s10096-007-0298-0
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control.2006
- Global Incidence of Multidrug‐Resistant TuberculosisThe Journal of Infectious Diseases, 2006
- Faculty Opinions recommendation of Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.Published by H1 Connect ,2006
- Molecular Analysis of Cross-Resistance to Capreomycin, Kanamycin, Amikacin, and Viomycin in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2005
- Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Correlation between Quinolone Susceptibility Patterns and Sequences in the A and B Subunits of DNA Gyrase in MycobacteriaAntimicrobial Agents and Chemotherapy, 1998
- Failure of drug penetration and acquisition of drug resistance in chronic tuberculous empyemaTubercle and Lung Disease, 1995
- [Enterobacter cloacae. In vivo emergence of a variant resistant to new beta-lactams during treatment with lamoxactam-gentamicin].1984